Not Tagged
Not Tagged
['gu ', 'pcsm', 'prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
a longer course of adt does not improve outcomes in patients with localized, high-risk prostate cancer receiving i-125 brachytherapy and external beam radiotherapy, a phase 3 trial presented at asco gu 2023 suggests. #gu23 #pcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.